The usefulness of thyroid size and TSH receptor antibody (TRAb) determinations in predicting the effectiveness of tiamazole and I-131 treatment for Graves-Basedow's disease.

Annales Universitatis Mariae Curie-Skłodowska. Sectio D: Medicina

Volumn 58, Issue 1, 2003, Pages 242-247

  Bojarska Szmygin, Anna ^a   Janicki, Krzysztof ^a   Pietura, Radosław ^a   Janicka, Lucyna ^a  

^a Cardinal Stefan Wyszynski Regional Specialised Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; AUTOANTIBODY; BIOLOGICAL MARKER; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN BINDING INHIBITORY IMMUNOGLOBULIN; THYROTROPIN RECEPTOR; THYROTROPIN-BINDING INHIBITORY IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GRAVES DISEASE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; THYROID GLAND; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTITHYROID AGENTS; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MALE; METHIMAZOLE; MIDDLE AGED; RECEPTORS, THYROTROPIN; THYROID GLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 7444261274     PISSN: 00662240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)